Colleague's E-mail is Invalid
Your message has been successfully sent to your colleague.
Save my selection
Santelmann, Heikoa; Howard, John McLarenb
aHolistisk Senter, Oslo, Norway, andbBiolab Medical Unit, London, UK.
Correspondence to Dr Heiko Santelmann, Holmenveien 1, N-0374 Oslo, Norway. Tel: +47 22139510; fax: +47 22139513; e-mail:[email protected]
Many patients with irritable bowel syndrome (IBS) are disillusioned by the lack of efficacy of treatments and suffer from numerous symptoms not covered by the Rome criteria for IBS, as the current empirical treatment regimens fail to address these persistent debilitating ‘IBS associated symptoms’. These symptoms are similar to other symptom complexes like chronic fatigue and the so-called ‘candida syndrome’, and many seek help from alternative medicine. The possible role ofCandida and yeasts in non-immune compromised individuals is disputed and is the subject of this review. Even if the involvement of yeasts in the aetiology of IBS still remains unclear, there is increasing evidence for yeasts being able to cause IBS-symptoms in sensitized patients viaCandida products, antigens and cross-antigens. But more research is needed before antifungal treatment can be recommended as a first line treatment for IBS.
You can read the full text of this article if you: